{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:28Z","timestamp":1788754108134,"version":"build-2803163510"},"reference-count":205,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Regulatory T cells (Tregs) maintain immune homeostasis, but in cancer the same FOXP3-dependent programme can be co-opted to protect malignant tissue from immune elimination. This review critically synthesizes spatially resolved, single-cell and mechanistic evidence to determine when tumour-associated Tregs constitute active components of suppressive multicellular niches rather than merely correlates of immune exclusion. We integrate tumour-adapted regulatory states with anatomical positioning, neighbouring malignant and non-malignant cells, candidate suppressive mechanisms and upstream tumour-intrinsic, stromal and myeloid programmes. This framework distinguishes Treg-dominant suppressive niches from Treg-associated architectures in which regulatory-cell accumulation is secondary to other resistance mechanisms. We examine tumour nests, invasive margins, dendritic-cell and lymphoid aggregates, stromal and perivascular barriers, and hypoxic or metabolically constrained regions, assessing the strength of evidence linking each context to local immune restraint. We further consider how these niches emerge during tumour progression, change under therapeutic pressure, and persist, relocate or re-form during resistance. We evaluate selective depletion strategies targeting CCR8, CD25 and CTLA-4, together with functional reprogramming of TGF-\u03b2, adenosine, kynurenine, lactate, hypoxia and IL-2 pathways. Finally, we propose a tiered biomarker framework integrating Treg phenotype, transcriptional state, spatiotemporal topology, functional immune competence and longitudinal pharmacodynamic validation. The contribution of this Review is therefore not the niche concept itself, but its Treg-centred mechanistic and translational operationalization for identifying tumour-specific regulatory dependencies while preserving systemic self-tolerance.<\/jats:p>","DOI":"10.3389\/fcell.2026.1921036","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:37:51Z","timestamp":1788752271000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatial Treg niches and the therapeutic reprogramming of tumour tolerance in cancer"],"prefix":"10.3389","volume":"14","author":[{"given":"Jhommara","family":"Bautista","sequence":"first","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Di Capua Delgado","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Viteri-Recalde","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ben\u00edtez-N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ram\u00edrez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"L\u00f3pez-Cort\u00e9s","sequence":"additional","affiliation":[{"name":"Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Am\u00e9ricas","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2017.05.002","article-title":"Regulatory T cells in skin facilitate epithelial stem cell differentiation","volume":"169","author":"Ali","year":"2017","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.immuni.2017.03.013","article-title":"Fc-Optimized Anti-CD25 depletes tumor-infiltrating regulatory T cells and synergizes with PD-1 blockade to eradicate established tumors","volume":"46","author":"Arce Vargas","year":"2017","journal-title":"Immunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e07571","DOI":"10.7554\/eLife.07571","article-title":"Genetic and epigenetic variation in the lineage specification of regulatory T cells","volume":"4","author":"Arvey","year":"2015","journal-title":"eLife"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e002231","DOI":"10.1136\/jitc-2020-002231","article-title":"Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade","volume":"9","author":"Banchereau","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.lungcan.2018.01.022","article-title":"Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer","volume":"117","author":"Barua","year":"2018","journal-title":"Lung Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1200\/JCO.2006.05.9584","article-title":"Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse","volume":"24","author":"Bates","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41514-026-00422-5","article-title":"Mitochondrial drivers of stem cell aging and inflammaging","volume":"12","author":"Bautista","year":"","journal-title":"Npj Aging"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1806570","DOI":"10.3389\/fimmu.2026.1806570","article-title":"The hallmarks of neuro-immune reprogramming in cancer","volume":"17","author":"Bautista","year":"","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"113550","DOI":"10.1016\/j.isci.2025.113550","article-title":"Neurodegeneration rewires the tumor microenvironment via the neuro-immune-cancer axis","volume":"28","author":"Bautista","year":"2025","journal-title":"iScience"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1857151","DOI":"10.3389\/fcimb.2026.1857151","article-title":"Programming the tumor microenvironment through microbiome-driven mechanisms","volume":"16","author":"Bautista","year":"","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"7864229","DOI":"10.1155\/jimr\/7864229","article-title":"Next\u2010generation immune checkpoints and tumor microenvironment modulation in cancer immunotherapy","volume":"2026","author":"Bautista","year":"","journal-title":"J. Immunol. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41522-025-00883-8","article-title":"Gut microbiome-driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming","volume":"12","author":"Bautista","year":"","journal-title":"Npj Biofilms Microbiomes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1172\/JCI89455","article-title":"Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy","volume":"127","author":"Beavis","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1128\/MCB.01206-10","article-title":"Sirtuin-1 targeting promotes Foxp3+ T-regulatory cell function and prolongs allograft survival","volume":"31","author":"Beier","year":"2011","journal-title":"Mol. Cell. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1182\/blood-2006-02-002774","article-title":"Regulatory T cells in cancer","volume":"108","author":"Beyer","year":"2006","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2019.02.005","article-title":"Unleashing Type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity","volume":"177","author":"Binnewies","year":"2019","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"CT232","DOI":"10.1158\/1538-7445.AM2026-CT232","article-title":"Abstract CT232: preliminary results of a phase 1, first-in-human, dose-escalation study of the anti-CCR8 antibody denikitug in participants with advanced solid tumors","volume":"86","author":"Bockorny","year":"2026","journal-title":"Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cels.2016.03.008","article-title":"Multiplexed epitope-based tissue imaging for discovery and healthcare applications","volume":"2","author":"Bodenmiller","year":"2016","journal-title":"Cell Syst."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2006-12-064527","article-title":"Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression","volume":"110","author":"Borsellino","year":"2007","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","article-title":"Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity","volume":"26","author":"Broz","year":"2014","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","article-title":"Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse","volume":"27","author":"Brunkow","year":"2001","journal-title":"Nat. Genet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1084\/jem.20130573","article-title":"Activating Fc \u03b3 receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies","volume":"210","author":"Bulliard","year":"2013","journal-title":"J. Exp. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1038\/s41591-024-03083-7","article-title":"Botensilimab plus balstilimab in relapsed\/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial","volume":"30","author":"Bullock","year":"2024","journal-title":"Nat. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special population of regulatory T cells potentiates muscle repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"key":"B29","doi-asserted-by":"publisher","first-page":"112434","DOI":"10.1016\/j.intimp.2024.112434","article-title":"Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients","volume":"137","author":"Cai","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1158\/0008-5472.CAN-20-3585","article-title":"Fc-Optimized Anti-CCR8 antibody depletes regulatory T cells in human tumor models","volume":"81","author":"Campbell","year":"2021","journal-title":"Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.immuni.2007.08.014","article-title":"Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance","volume":"27","author":"Cao","year":"2007","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature13981","article-title":"Intracellular \u03b1-ketoglutarate maintains the pluripotency of embryonic stem cells","volume":"518","author":"Carey","year":"2015","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/s41467-023-40398-4","article-title":"Combined PD-L1\/TGF\u03b2 blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors","volume":"14","author":"Castiglioni","year":"2023","journal-title":"Nat. Commun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/s41467-018-04392-5","article-title":"mTOR coordinates transcriptional programs and mitochondrial metabolism of activated Treg subsets to protect tissue homeostasis","volume":"9","author":"Chapman","year":"2018","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in Treg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","article-title":"PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells","volume":"486","author":"Cipolletta","year":"2012","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","first-page":"eadl6464","DOI":"10.1126\/sciadv.adl6464","article-title":"Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses","volume":"10","author":"Cole","year":"2024","journal-title":"Sci. Adv."},{"key":"B40","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","article-title":"Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival","volume":"10","author":"Curiel","year":"2004","journal-title":"Nat. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.1073\/pnas.0915174107","article-title":"PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors","volume":"107","author":"Curran","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B42","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1172\/JCI25947","article-title":"Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells","volume":"115","author":"Dannull","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional landscape of human tissue lymphocytes unveils uniqueness of tumor-infiltrating T regulatory cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J. Exp. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","article-title":"The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment","volume":"30","author":"Delgoffe","year":"2009","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nm1707","article-title":"Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells","volume":"14","author":"Ding","year":"2008","journal-title":"Nat. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.4049\/jimmunol.1402711","article-title":"CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients","volume":"194","author":"Djenidi","year":"2015","journal-title":"J. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1158\/1078-0432.CCR-19-1090","article-title":"A phase I study of the Anti-CC chemokine receptor 4 antibody, mogamulizumab, in combination with nivolumab in patients with advanced or metastatic solid tumors","volume":"25","author":"Doi","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-07-5664","article-title":"The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells","volume":"68","author":"Ebert","year":"2008","journal-title":"Cancer Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41698-025-00973-y","article-title":"A temporal model of tumor-immune dynamics during the metastatic progression of high-grade serous ovarian cancer","volume":"9","author":"Egan","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1158\/2159-8290.CD-23-1380","article-title":"Spatial architecture of myeloid and T cells orchestrates immune evasion and clinical outcome in lung cancer","volume":"14","author":"Enfield","year":"2024","journal-title":"Cancer Discov."},{"key":"B54","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s42003-022-03368-y","article-title":"A framework for multiplex imaging optimization and reproducible analysis","volume":"5","author":"Eng","year":"2022","journal-title":"Commun. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41590-021-00958-6","article-title":"Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy","volume":"22","author":"Eschweiler","year":"2021","journal-title":"Nat. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41590-020-0674-9","article-title":"Type 1 Treg cells promote the generation of CD8+ tissue-resident memory T cells","volume":"21","author":"Ferreira","year":"2020","journal-title":"Nat. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nm.2002","article-title":"Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters","volume":"15","author":"Feuerer","year":"2009","journal-title":"Nat. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/sji.12615","article-title":"The dual role of treg in cancer","volume":"86","author":"Frydrychowicz","year":"2017","journal-title":"Scand. J. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"B63","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2767-9764.CRC-24-0638","article-title":"Safety and antitumor activity of a novel aCD25 Treg depleter RG6292 as a single agent and in combination with atezolizumab in patients with solid tumors","volume":"5","author":"Gambardella","year":"2025","journal-title":"Cancer Res. Commun."},{"key":"B64","doi-asserted-by":"publisher","first-page":"6659","DOI":"10.1073\/pnas.0509484103","article-title":"Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development","volume":"103","author":"Gavin","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B65","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1\/Anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"key":"B66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat. Methods"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41467-021-23331-5","article-title":"CRISPR\/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy","volume":"12","author":"Giuffrida","year":"2021","journal-title":"Nat. Commun."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41590-023-01504-2","article-title":"Conserved transcriptional connectivity of regulatory T cells in the tumor microenvironment informs new combination cancer therapy strategies","volume":"24","author":"Glasner","year":"2023","journal-title":"Nat. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-08-2360","article-title":"Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep profiling of mouse splenic architecture with CODEX multiplexed imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1200\/JCO.2024.42.16_suppl.2504","article-title":"Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: results from phase 1\/2 studies","volume":"42","author":"Gong","year":"2024","journal-title":"JCO"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"B73","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","article-title":"Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing","volume":"24","author":"Guo","year":"2018","journal-title":"Nat. Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s43018-021-00221-9","article-title":"Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma","volume":"2","author":"Haas","year":"2021","journal-title":"Nat. Cancer"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s43018-025-01039-5","article-title":"Spatiotemporal analyses of the pan-cancer single-cell landscape reveal widespread profibrotic ecotypes associated with tumor immunity","volume":"6","author":"Han","year":"2025","journal-title":"Nat. Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"B77","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1053\/j.gastro.2023.10.022","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13+CD103+CD8+ tissue-resident memory T-Cell response to programmed cell death protein 1 blockade in cancer immunotherapy","volume":"166","author":"Hu","year":"2024","journal-title":"Gastroenterology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41423-021-00742-4","article-title":"Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy","volume":"19","author":"Huppert","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/35001622","article-title":"Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","article-title":"The single-cell pathology landscape of breast cancer","volume":"578","author":"Jackson","year":"2020","journal-title":"Nature"},{"key":"B84","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1158\/2159-8290.CD-17-0833","article-title":"Ex Vivo profiling of PD-1 blockade using organotypic tumor spheroids","volume":"8","author":"Jenkins","year":"2018","journal-title":"Cancer Discov."},{"key":"B85","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","article-title":"A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade","volume":"175","author":"Jerby-Arnon","year":"2018","journal-title":"Cell"},{"key":"B86","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu. Rev. Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B88","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1479-5876-6-19","article-title":"Foxp3 expression in human cancer cells","volume":"6","author":"Karanikas","year":"2008","journal-title":"J. Transl. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"7275","DOI":"10.1158\/1078-0432.CCR-19-2030","article-title":"FDA approval summary: mogamulizumab-kpkc for mycosis fungoides and s\u00e9zary syndrome","volume":"25","author":"Kasamon","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.cell.2018.08.039","article-title":"A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging","volume":"174","author":"Keren","year":"2018","journal-title":"Cell"},{"key":"B91","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","article-title":"An essential role for scurfin in CD4+CD25+ T regulatory cells","volume":"4","author":"Khattri","year":"2003","journal-title":"Nat. Immunol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"e2114282119","DOI":"10.1073\/pnas.2114282119","article-title":"CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory","volume":"119","author":"Kidani","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e53630","DOI":"10.1371\/journal.pone.0053630","article-title":"Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS ONE"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41590-026-02540-4","article-title":"Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases","volume":"27","author":"Koh","year":"2026","journal-title":"Nat. Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1038\/s41467-025-60929-5","article-title":"Constitutive expression of the transcriptional co-activator I\u03baB\u03b6 promotes melanoma growth and immunotherapy resistance","volume":"16","author":"Kolb","year":"2025","journal-title":"Nat. Commun."},{"key":"B97","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20050930","article-title":"B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma","volume":"203","author":"Kryczek","year":"2006","journal-title":"J. Exp. Med."},{"key":"B98","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1652047","DOI":"10.3389\/fcell.2025.1652047","article-title":"Reprogramming cancer immunity with next-generation combination therapies","volume":"13","author":"Kyriakidis","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1038\/s41467-021-26352-2","article-title":"Regulatory T cells promote cancer immune-escape through integrin \u03b1v\u03b28-mediated TGF-\u03b2 activation","volume":"12","author":"Lain\u00e9","year":"2021","journal-title":"Nat. Commun."},{"key":"B101","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2017.04.014","article-title":"Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses","volume":"169","author":"Lavin","year":"2017","journal-title":"Cell"},{"key":"B102","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41592-022-01480-9","article-title":"Benchmarking spatial and single-cell transcriptomics integration methods for transcript distribution prediction and cell type deconvolution","volume":"19","author":"Li","year":"","journal-title":"Nat. Methods"},{"key":"B103","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/s41467-022-33768-x","article-title":"TGF-\u03b2-dependent lymphoid tissue residency of stem-like T cells limits response to tumor vaccine","volume":"13","author":"Li","year":"","journal-title":"Nat. Commun."},{"key":"B104","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aau2909","article-title":"Structural basis of latent TGF-\u03b21 presentation and activation by GARP on human regulatory T cells","volume":"362","author":"Li\u00e9nart","year":"2018","journal-title":"Science"},{"key":"B105","doi-asserted-by":"publisher","first-page":"117189","DOI":"10.1016\/j.celrep.2026.117189","article-title":"Regulatory T cell-derived TGF-\u03b2 signaling governs the differentiation and maintenance of tumor-infiltrating bystander CD8+ T cells","volume":"45","author":"Lin","year":"2026","journal-title":"Cell Rep."},{"key":"B106","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1038\/s41591-025-04032-8","article-title":"Adjuvant nivolumab and relatlimab in stage III\/IV melanoma: the randomized phase 3 RELATIVITY-098 trial","volume":"31","author":"Long","year":"2025","journal-title":"Nat. Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1268979","DOI":"10.3389\/fimmu.2023.1268979","article-title":"Targeting regulatory T cells by E7777 enhances CD8 T-cell-mediated anti-tumor activity and extends survival benefit of anti-PD-1 in solid tumor models","volume":"14","author":"Mahdi","year":"2023","journal-title":"Front. Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-020-2134-y","article-title":"A conserved dendritic-cell regulatory program limits antitumour immunity","volume":"580","author":"Maier","year":"2020","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-022-04718-w","article-title":"Extricating human tumour immune alterations from tissue inflammation","volume":"605","author":"Mair","year":"2022","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1074\/jbc.M109.047423","article-title":"Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells","volume":"285","author":"Mandapathil","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav5728","article-title":"Migratory DCs activate TGF-\u03b2 to precondition na\u00efve CD8+ T cells for tissue-resident memory fate","volume":"366","author":"Mani","year":"2019","journal-title":"Science"},{"key":"B112","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B113","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","article-title":"Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism","volume":"22","author":"Mentch","year":"2015","journal-title":"Cell Metab."},{"key":"B114","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","article-title":"An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells","volume":"185","author":"Mezrich","year":"2010","journal-title":"J. Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","article-title":"Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets","volume":"186","author":"Michalek","year":"2011","journal-title":"J. Immunol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature24993","article-title":"Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours","volume":"552","author":"Milner","year":"2017","journal-title":"Nature"},{"key":"B118","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/ijc.23392","article-title":"CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer","volume":"122","author":"Mizukami","year":"2008","journal-title":"Int. J. Cancer"},{"key":"B120","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12967-024-05035-8","article-title":"Spatial insights into immunotherapy response in non-small cell lung cancer (NSCLC) by multiplexed tissue imaging","volume":"22","author":"Monkman","year":"2024","journal-title":"J. Transl. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imm.13058","article-title":"Treg programming and therapeutic reprogramming in cancer","volume":"157","author":"Moreno Ayala","year":"2019","journal-title":"Immunology"},{"key":"B122","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1158\/2326-6066.CIR-17-0040","article-title":"Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment","volume":"5","author":"Muroyama","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fcgamma receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/ijc.25429","article-title":"Regulatory T cells in tumor immunity","volume":"127","author":"Nishikawa","year":"2010","journal-title":"Int. J. Cancer"},{"key":"B126","doi-asserted-by":"publisher","first-page":"15221","DOI":"10.1038\/ncomms15221","article-title":"Induction of resident memory T cells enhances the efficacy of cancer vaccine","volume":"8","author":"Nizard","year":"2017","journal-title":"Nat. Commun."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1158\/0008-5472.CAN-11-3758","article-title":"Cancer vaccination drives Nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotype","volume":"72","author":"Noh","year":"2012","journal-title":"Cancer Res."},{"key":"B128","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.immuni.2012.09.010","article-title":"T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development","volume":"37","author":"Ohkura","year":"2012","journal-title":"Immunity"},{"key":"B129","doi-asserted-by":"publisher","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/ni1536","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells","volume":"8","author":"Pandiyan","year":"2007","journal-title":"Nat. Immunol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032712-095948","article-title":"Tissue tregs","volume":"34","author":"Panduro","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1158\/1078-0432.CCR-23-2124","article-title":"FDA approval summary: tremelimumab in combination with durvalumab for the treatment of patients with unresectable hepatocellular carcinoma","volume":"30","author":"Patel","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"B133","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"B134","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to T cell-mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov."},{"key":"B135","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-022-29930-0","article-title":"PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration","volume":"13","author":"Piao","year":"2022","journal-title":"Nat. Commun."},{"key":"B136","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1084\/jem.20071341","article-title":"OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection","volume":"205","author":"Piconese","year":"2008","journal-title":"J. Exp. Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"key":"B138","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cell.2017.10.044","article-title":"Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer","volume":"171","author":"Puram","year":"2017","journal-title":"Cell"},{"key":"B140","doi-asserted-by":"publisher","first-page":"114392","DOI":"10.1016\/j.celrep.2024.114392","article-title":"Single-cell spatial multiomics reveals tumor microenvironment vulnerabilities in cancer resistance to immunotherapy","volume":"43","author":"Quek","year":"2024","journal-title":"Cell Rep."},{"key":"B141","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1126\/science.1202947","article-title":"Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4","volume":"332","author":"Qureshi","year":"2011","journal-title":"Science"},{"key":"B142","doi-asserted-by":"publisher","first-page":"102835","DOI":"10.18632\/oncotarget.22159","article-title":"Regulatory T cells characterized by low Id3 expression are highly suppressive and accumulate during chronic infection","volume":"8","author":"Rauch","year":"2017","journal-title":"Oncotarget"},{"key":"B143","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1158\/2326-6066.CIR-15-0210","article-title":"PD-1 blockade expands intratumoral memory T cells","volume":"4","author":"Ribas","year":"2016","journal-title":"Cancer Immunol. Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","article-title":"Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma","volume":"30","author":"Roberts","year":"2016","journal-title":"Cancer Cell"},{"key":"B145","doi-asserted-by":"publisher","first-page":"e004991","DOI":"10.1136\/jitc-2022-004991","article-title":"TransCon IL-2 \u03b2\/\u03b3: a novel long-acting prodrug with sustained release of an IL-2R\u03b2\/\u03b3-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer","volume":"10","author":"Rosen","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"B146","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","article-title":"Defining T cell states associated with response to checkpoint immunotherapy in melanoma","volume":"175","author":"Sade-Feldman","year":"2018","journal-title":"Cell"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1158\/2326-6066.CIR-20-0034","article-title":"An antibody targeting ICOS increases intratumoral cytotoxic to regulatory T-cell ratio and induces tumor regression","volume":"8","author":"Sainson","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nm.4086","article-title":"Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers","volume":"22","author":"Saito","year":"2016","journal-title":"Nat. Med."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/ni.1840","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1034\/j.1600-065X.2001.1820102.x","article-title":"Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance","volume":"182","author":"Sakaguchi","year":"2001","journal-title":"Immunol. Rev."},{"key":"B151","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B152","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1200\/JCO.2008.18.7229","article-title":"Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer","volume":"27","author":"Salama","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","article-title":"Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition","volume":"44","author":"Salmon","year":"2016","journal-title":"Immunity"},{"key":"B154","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","article-title":"Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis","volume":"24","author":"Savas","year":"2018","journal-title":"Nat. Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41592-021-01308-y","article-title":"MCMICRO: a scalable, modular image-processing pipeline for multiplexed tissue imaging","volume":"19","author":"Schapiro","year":"","journal-title":"Nat. Methods"},{"key":"B156","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41592-022-01415-4","article-title":"MITI minimum information guidelines for highly multiplexed tissue images","volume":"19","author":"Schapiro","year":"","journal-title":"Nat. Methods"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41592-025-02770-8","article-title":"Scaling up spatial transcriptomics for large-sized tissues: uncovering cellular-level tissue architecture beyond conventional platforms with iSCALE","volume":"22","author":"Schroeder","year":"2025","journal-title":"Nat. Methods"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"key":"B159","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2326-6066.CIR-13-0013","article-title":"Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells","volume":"1","author":"Selby","year":"2013","journal-title":"Cancer Immunol. Res."},{"key":"B160","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J. Exp. Med."},{"key":"B161","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1158\/0008-5472.CAN-18-0365","article-title":"Oncogenic BRAFV600E governs regulatory T-cell recruitment during melanoma tumorigenesis","volume":"78","author":"Shabaneh","year":"2018","journal-title":"Cancer Res."},{"key":"B162","doi-asserted-by":"publisher","first-page":"15179","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci. Rep."},{"key":"B163","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1172\/JCI31911","article-title":"Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase","volume":"117","author":"Sharma","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1158\/1078-0432.CCR-18-0762","article-title":"Anti-CTLA-4 immunotherapy does not deplete FOXP3+ regulatory T cells (Tregs) in human cancers","volume":"25","author":"Sharma","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"B165","doi-asserted-by":"publisher","first-page":"12928","DOI":"10.3390\/ijms150712928","article-title":"WNT16B from ovarian fibroblasts induces differentiation of regulatory T cells through \u03b2-catenin signal in dendritic cells","volume":"15","author":"Shen","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B166","doi-asserted-by":"publisher","first-page":"5211","DOI":"10.4049\/jimmunol.163.10.5211","article-title":"Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity","volume":"163","author":"Shimizu","year":"1999","journal-title":"J. Immunol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"B168","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1084\/jem.20130579","article-title":"Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma","volume":"210","author":"Simpson","year":"2013","journal-title":"J. Exp. Med."},{"key":"B170","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","article-title":"CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity","volume":"1","author":"Solomon","year":"2020","journal-title":"Nat. Cancer"},{"key":"B171","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"B172","doi-asserted-by":"publisher","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/s41590-018-0236-6","article-title":"Activated \u03b2-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity","volume":"19","author":"Sumida","year":"2018","journal-title":"Nat. Immunol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/eji.201847659","article-title":"Targeting Treg cells in cancer immunotherapy","volume":"49","author":"Tanaka","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"B176","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B177","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"B178","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/ni1549","article-title":"Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer","volume":"9","author":"Tone","year":"2008","journal-title":"Nat. Immunol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1158\/2326-6066.CIR-24-0184","article-title":"Lung cancer-intrinsic SOX2 expression mediates resistance to checkpoint blockade therapy by inducing treg-dependent CD8+ T-cell exclusion","volume":"13","author":"Torres-Mejia","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1073\/pnas.0901944106","article-title":"GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells","volume":"106","author":"Tran","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B181","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-25-3447","article-title":"Safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy from a first-in-human study of volrustomig, a novel PD-1\/CTLA-4 bispecific antibody","volume":"32","author":"Tran","year":"2026","journal-title":"Clin. Cancer Res."},{"key":"B182","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41577-023-00893-7","article-title":"The role of transcription factors in shaping regulatory T cell identity","volume":"23","author":"Trujillo-Ochoa","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"B184","doi-asserted-by":"publisher","first-page":"e001749","DOI":"10.1136\/jitc-2020-001749","article-title":"Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy","volume":"9","author":"Van Damme","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"B185","doi-asserted-by":"publisher","first-page":"e19047","DOI":"10.1371\/journal.pone.0019047","article-title":"Rapid temporal control of Foxp3 protein degradation by sirtuin-1","volume":"6","author":"van Loosdregt","year":"2011","journal-title":"PLoS ONE"},{"key":"B186","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cellimm.2018.07.011","article-title":"Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors","volume":"332","author":"Vermeersch","year":"2018","journal-title":"Cell. Immunol."},{"key":"B187","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"B188","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/onc.2016.458","article-title":"Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+Treg cells in pancreatic ductal adenocarcinoma","volume":"36","author":"Wang","year":"2017","journal-title":"Oncogene"},{"key":"B189","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1158\/1535-7163.MCT-25-0367","article-title":"CHS-114: an afucosylated Anti-CCR8 monoclonal antibody that selectively depletes intratumoral treg cells and induces antitumor immune responses","volume":"25","author":"Wang","year":"2026","journal-title":"Mol. Cancer Ther."},{"key":"B190","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B191","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1158\/1078-0432.CCR-13-1877","article-title":"Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer","volume":"20","author":"Webb","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"B192","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41586-018-0846-z","article-title":"Mitochondrial complex III is essential for suppressive function of regulatory T cells","volume":"565","author":"Weinberg","year":"2019","journal-title":"Nature"},{"key":"B193","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"B194","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/imm.13337","article-title":"CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function","volume":"163","author":"Whiteside","year":"2021","journal-title":"Immunology"},{"key":"B195","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1126\/science.1160062","article-title":"CTLA-4 control over Foxp3+ regulatory T cell function","volume":"322","author":"Wing","year":"2008","journal-title":"Science"},{"key":"B196","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.immuni.2015.04.012","article-title":"Integrin \u03b1v\u03b28-Mediated TGF-\u03b2 activation by effector regulatory T cells is essential for suppression of T-Cell-Mediated inflammation","volume":"42","author":"Worthington","year":"2015","journal-title":"Immunity"},{"key":"B197","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"B198","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/s41592-024-02325-3","article-title":"Systematic comparison of sequencing-based spatial transcriptomic methods","volume":"21","author":"You","year":"2024","journal-title":"Nat. Methods"},{"key":"B199","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1084\/jem.20151438","article-title":"Control of Foxp3 stability through modulation of TET activity","volume":"213","author":"Yue","year":"2016","journal-title":"J. Exp. Med."},{"key":"B200","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1158\/1078-0432.CCR-20-0328","article-title":"Mogamulizumab in combination with durvalumab or tremelimumab in patients with advanced solid tumors: a phase I study","volume":"26","author":"Zamarin","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B201","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B202","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish t(reg)-cell function","volume":"499","author":"Zeng","year":"2013","journal-title":"Nature"},{"key":"B203","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/cmi.2015.57","article-title":"Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment","volume":"12","author":"Zhang","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","article-title":"Lineage tracking reveals dynamic relationships of T cells in colorectal cancer","volume":"564","author":"Zhang","year":"2018","journal-title":"Nature"},{"key":"B205","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1158\/2159-8290.CD-19-0958","article-title":"Regulatory T-cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Cancer Discov."},{"key":"B206","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1921036\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:37:53Z","timestamp":1788752273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1921036\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":205,"alternative-id":["10.3389\/fcell.2026.1921036"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1921036","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"1921036"}}